Research Progress on Clinical Treatment of Hemangioma and Vascular Malformation in Children

Abstract

Abstract: Childhood hemangioma is a common benign tumor composed of vascular endothelial cells that occurs mostly in children, with a high incidence rate, generally 4–10%. The incidence rate is as high as 75% within a few weeks after birth, especially in the skin and subcutaneous tissue. Hemangioma can be invasive, growing rapidly, and may lead to spontaneous ulceration. It can also regress on its own. When it affects multiple areas on the head and face, it can create a significant mental and psychological burden for both children and parents. Treatment methods for hemangiomas have become more mature, with expert consensus and clinical practice guidelines available. Understanding of how these treatments work has also improved. It is important to review the available treatment options to assist both healthcare providers and parents in choosing the most suitable treatment for children with hemangiomas. This helps in making informed decisions about treatment methods.